Taking Control Of Your Diabetes® - The Podcast!

Hot flashes, blood sugar swings, brain fog... is it menopause, diabetes, or both?

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by renowned menopause expert Dr. Cindy Stuenkel, endocrinologist and Professor Emerita at UC San Diego, for an insightful conversation about how menopause affects women living with diabetes. Together, they explain why menopause is much more than a normal stage of aging. It's a major metabolic transition that can influence blood sugar management, insulin resistance, heart health, sleep, mood, and overall quality of life. 
The conversation explores what actually happens during perimenopause, menopause, and postmenopause, why hormonal fluctuations can make glucose management more challenging, and how continuous glucose monitoring can help distinguish hot flashes from hypoglycemia. Dr. Edelman and Dr. Stuenkel also discuss the latest evidence on hormone replacement therapy, newer non-hormonal treatment options, the importance of protecting heart health, and practical strategies to help women navigate this stage of life with greater confidence. Whether you're living with type 1 or type 2 diabetes, approaching menopause, currently experiencing it, or supporting someone who is, this episode provides practical guidance and evidence-based information to help you feel more prepared. 
Key Topics:
What is perimenopause, menopause, and postmenopause?
How hormonal changes affect blood sugar and insulin resistance
Why menopause can increase glucose variability in women with diabetes
The difference between hot flashes and hypoglycemia
How continuous glucose monitoring can help during menopause
Metabolic changes that occur during the menopause transition
Why cardiovascular risk increases after menopause
The connection between menopause, weight gain, and abdominal fat
GLP-1 medications and menopause
The latest recommendations on hormone replacement therapy
New non-hormonal treatments for hot flashes
Sleep, mood, brain fog, and quality of life during menopause
Heart health strategies for women living with diabetes
How partners can better support someone going through menopause
Trusted menopause resources and when to seek medical care
✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram:   / tcoyd
Facebook:   / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★

Have you or someone you know been diagnosed with type 2 diabetes, only to discover later it was actually type 1? You're not alone.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Dr. Schaefer Boeder, endocrinologist, Medical Director of Paradigm Research, Associate Professor at UCSD, for an eye-opening discussion about LADA (Latent Autoimmune Diabetes in Adults)—one of the most commonly misdiagnosed conditions in diabetes. Together, they explain why so many adults are initially misdiagnosed with type 2 diabetes despite the warning signs that should raise suspicion for LADA, and why getting the correct diagnosis can dramatically change treatment and long-term outcomes.
The conversation explores how LADA differs from both classic type 1 and type 2 diabetes, why the autoimmune process develops more slowly, and when antibody testing should be considered. Dr. Edelman and Dr. Boeder also discuss the importance of preserving beta cell function, the role of continuous glucose monitoring, advances in disease-modifying therapies, and why there has never been a more exciting time for research in adults who developed type 1 diabetes later in life. Whether you've been diagnosed with LADA, care for someone who has, or simply want to better understand adult-onset autoimmune diabetes, this episode provides practical guidance and hope for more accurate diagnoses in the future.

Key Topics:
What is LADA (Latent Autoimmune Diabetes in Adults)?
Why LADA is so often mistaken for type 2 diabetes
Common signs that may point to a misdiagnosis
How LADA differs from classic type 1 and type 2 diabetes
Why many adults don't fit the "typical" diabetes profile
Autoantibody testing and when it should be considered
The role of GAD antibodies and C-peptide testing
Why preserving beta cell function matters
Preventing diabetic ketoacidosis (DKA) through earlier diagnosis
How continuous glucose monitoring can ease the transition to insulin
Current treatment approaches for adults with LADA
The latest research on disease-modifying therapies and preserving insulin production
Screening resources, clinical trials, and where the future of LADA research is headed
✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram:   / tcoyd
Facebook:   / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by Dr. Shara Bialo, Senior Medical Director of Type 1 Diabetes Immunology at Sanofi, pediatric endocrinologist, and person living with type 1 diabetes, for an in-depth discussion about what happens before type 1 diabetes is diagnosed. Together, they explore the autoimmune process that begins months or even years before symptoms appear, why early detection matters, and how screening is changing the future of type 1 diabetes care. 
Dr. Bialo shares her personal diagnosis story, discusses common misconceptions about what causes type 1 diabetes, and explains the three stages of the disease. The conversation also covers who should be screened, how diabetes autoantibody testing works, the benefits of preserving beta cell function, and why identifying people before they develop symptoms can lead to better long-term outcomes and fewer cases of diabetic ketoacidosis (DKA). Whether you have type 1 diabetes, have a family member at risk, or simply want to better understand the latest advances in prevention and early detection, this episode provides valuable insights into one of the fastest-moving areas of diabetes research.
Key Topics:
Dr. Shara Bialo's personal journey living with type 1 diabetes
Why type 1 diabetes is an autoimmune disease, not simply a blood sugar problem
The role of genetics, viral infections, and the immune system
Understanding the three stages of type 1 diabetes
Why most people diagnosed with type 1 diabetes have no family history
Adult-onset type 1 diabetes and why it is often mistaken for type 2 diabetes
What diabetes autoantibodies are and how screening works
Who should consider screening for type 1 diabetes
Available screening options, including blood tests and home screening kits
The emotional challenges families face when considering screening
The importance of preventing diabetic ketoacidosis through early detection
Why preserving beta cell function can improve long-term outcomes
Italy's national screening program and the future of population-wide screening
Resources available through screenfortype1.com
This content was produced with support from Sanofi and screenfortype1.com.

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram:   / tcoyd
Facebook:   / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes. 
Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal.
Whether you’re the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives.
✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram:   / tcoyd
Facebook:   / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip’s dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.
The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.
Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.

Key Topics
• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes
• The design and results of the INHALE-1 pediatric clinical trial
• Patient satisfaction and quality-of-life outcomes from the study
• The challenges of pre-bolusing and mealtime insulin management in children and teens
• How inhaled insulin compares to traditional mealtime injections
• Dosing strategies, cartridge sizes, and insulin conversion considerations
• Using Afrezza for corrections, meals, and post-meal dosing
• The role of continuous glucose monitoring (CGM) when using inhaled insulin
• Safety findings, lung-function monitoring, and cough management
• Who may be a good candidate for Afrezza—and who may not be
• Benefits for active children, athletes, and those participating in sports
• Social situations, injection avoidance, and reducing the burden of diabetes management
• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems
• The importance of having more treatment options to individualize diabetes care
Supported by an unrestricted educational grant from MannKind Corporation

Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.
More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★